Evidence map›Paper›PMID 24586641›Full record

ArticlePloS one2014

T cell receptor signaling can directly enhance the avidity of CD28 ligand binding.

Mariano Sanchez-Lockhart, Ana V Rojas, Margaret M Fettis, Richard Bauserman, Trissha R Higa, Hongyu Miao, Richard E Waugh, Jim Miller

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Early T cell receptor signals globally modulate ligand:receptor affinities during antigen discrimination.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  17. BetaBiochimica et biophysica acta. Biomembranes · 2017
    Article
  18. Review
  19. Superantigens hyperinduce inflammatory cytokines by enhancing the B7-2/CD28 costimulatory receptor interaction.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Mariano Sanchez-LockhartDavid H Smith Center for Vaccine Biology and Immunology and Department of Microbiology and Immunology, University of Rochester, Rochester, New York, United States of America.
Ana V RojasDepartment of Biostatistics and Computational Biology, University of Rochester, Rochester, New York, United States of America.
Margaret M FettisDavid H Smith Center for Vaccine Biology and Immunology and Department of Microbiology and Immunology, University of Rochester, Rochester, New York, United States of America.
Richard BausermanDepartment of Biomedical Engineering, University of Rochester, Rochester, New York, United States of America.
Trissha R HigaDavid H Smith Center for Vaccine Biology and Immunology and Department of Microbiology and Immunology, University of Rochester, Rochester, New York, United States of America.
Hongyu MiaoDepartment of Biostatistics and Computational Biology, University of Rochester, Rochester, New York, United States of America.
Richard E WaughDepartment of Biomedical Engineering, University of Rochester, Rochester, New York, United States of America.
Jim MillerDavid H Smith Center for Vaccine Biology and Immunology and Department of Microbiology and Immunology, University of Rochester, Rochester, New York, United States of America.
University of Rochester · US

Funding

VASCULAR RELATIONS OF BLOOD CELLS AND PROTEINSP01HL018208 · NHLBI · UNIVERSITY OF ROCHESTER · PI WAUGH, RICHARD E · 1985 to 2014
$24.7M
Training in Biostatistics for HIV/AIDST32AI083206 · NIAID · UNIVERSITY OF ROCHESTER · PI QIU, XING · 2010 to 2014
$952k
Targeting CD28 ligand bindingR21AI105621 · NIAID · UNIVERSITY OF ROCHESTER · PI MILLER, JIM F · 2013 to 2014
$422k
CD28 TriggeringR21AI090259 · NIAID · UNIVERSITY OF ROCHESTER · PI MILLER, JIM F · 2010 to 2011
$421k
NHLBI NIH HHS P01 HL018208NIAID NIH HHS AI090259NIAID NIH HHS AI105621NIAID NIH HHS AI83206NIAID NIH HHS R21 AI090259NIAID NIH HHS R21 AI105621NIAID NIH HHS T32 AI083206
6 · The paper itself

Abstract

T cell activation takes place in the context of a spatial and kinetic reorganization of cell surface proteins and signaling molecules at the contact site with an antigen presenting cell, termed the immunological synapse. Coordination of the activation, recruitment, and signaling from T cell receptor (TCR) in conjunction with adhesion and costimulatory receptors regulates both the initiation and duration of signaling that is required for T cell activation. The costimulatory receptor, CD28, is an essential signaling molecule that determines the quality and quantity of T cell immune responses. Although the functional consequences of CD28 engagement are well described, the molecular mechanisms that regulate CD28 function are largely unknown. Using a micropipet adhesion frequency assay, we show that TCR signaling enhances the direct binding between CD28 and its ligand, CD80. Although CD28 is expressed as a homodimer, soluble recombinant CD28 can only bind ligand monovalently. Our data suggest that the increase in CD28-CD28 binding is mediated through a change in CD28 valency. Molecular dynamic simulations and in vitro mutagenesis indicate that mutations at the base of the CD28 homodimer interface, distal to the ligand-binding site, can induce a change in the orientation of the dimer that allows for bivalent ligand binding. When expressed in T cells, this mutation allows for high avidity CD28-CD80 interactions without TCR signaling. Molecular dynamic simulations also suggest that wild type CD28 can stably adopt a bivalent conformation. These results support a model whereby inside-out signaling from the TCR can enhance CD28 ligand interactions by inducing a change in the CD28 dimer interface to allow for bivalent ligand binding and ultimately the transduction of CD28 costimulatory signals that are required for T cell activation.

Indexed as

AnimalsB7-1 AntigenCD28 AntigensLigandsLymphocyte ActivationMiceMice, TransgenicMolecular Dynamics SimulationMutationReceptors, Antigen, T-CellRecombinant Fusion ProteinsSignal TransductionT-LymphocytesB7-1 AntigenCD28 AntigensLigandsReceptors, Antigen, T-CellRecombinant Fusion Proteins

Identifiers

PMID24586641
PMCPMC3933428
OpenAlexW2030690033

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.